Novorapid FlexPen
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Aspart (100IU/ml)
Overview Novorapid FlexPen
Insulin Aspart FlexPen (Novorapid) manages blood glucose in individuals with type 1 and type 2 diabetes. This rapid-acting insulin lowers post-meal blood sugar, mitigating the risk of diabetes-related complications. Typically prescribed alongside a longer-acting insulin or other diabetes medications, it's administered subcutaneously, as instructed by your healthcare provider, immediately before or within 20 minutes of eating. Regular blood glucose monitoring, recording, and sharing of results with your doctor are crucial for dose optimization. Avoid use with low blood sugar (hypoglycemia). Prior kidney, liver, or heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require consultation regarding dosage adjustments. Discontinuation should only occur under medical supervision. This medication forms part of a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management as advised. Common side effects include hypoglycemia, headache, upper respiratory infection, and nasopharyngitis. Accurate dosing, consistent meals, and regular blood glucose monitoring help minimize these. Excessive alcohol consumption may also trigger hypoglycemia. Additional side effects can include injection site reactions such as redness, swelling, or lipohypertrophy. Weight gain is a possibility with insulin therapy.
Uses of Novorapid FlexPen
Managing Diabetes Mellitus
Major Benefits of Novorapid FlexPen:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Novorapid FlexPen:
- Hypoglycemia (low blood glucose level)
- Headache
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
How to use Novorapid FlexPen:
Your healthcare provider will instruct you on the proper administration of this medication.
How Novorapid FlexPen works:
NovoRapid FlexPen, a rapid-onset insulin, begins to take effect 10 to 20 minutes post-injection. Its action mimics the body's natural insulin mechanism, promoting glucose absorption into muscle and fat tissues while simultaneously inhibiting hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Combining Novorapid FlexPen with alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
Using Novorapid FlexPen during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; yet, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
During lactation, the use of Novorapid FlexPen presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no known threat to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Novorapid FlexPen cautiously, as dose modification may be necessary. Physician consultation is advised. Regular blood glucose monitoring is recommended to guide appropriate dosage.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Novorapid FlexPen. Dosage modification may be necessary; physician consultation is recommended. Close, consistent blood glucose monitoring is advisable.
What if you forget to take Novorapid FlexPen :
Omitting a scheduled dose of Novorapid FlexPen can lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust your subsequent dose as needed.
Facts to Know About Novorapid FlexPen
| Label | Value |
|---|---|
| Chemical Type | Analog insulin |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Fast-acting insulin analogs |
3,018 People bought this recently